Form 4: Compass Pathways Director Malievskaia Sells Shares Under 10b5-1 Trading Plan

Ekaterina Malievskaia, a director at Compass Pathways plc, executed sales of ordinary shares under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Ekaterina Malievskaia, a director at Compass Pathways plc, reported the sale of ordinary shares on May 20 and May 21, 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted on August 23, 2023.
• On May 20, 2024, 6,704 shares were sold at a weighted average price of $7.892, with prices ranging from $7.80 to $7.99.
• On May 21, 2024, 8,900 shares were sold at a weighted average price of $7.9078, with prices ranging from $7.83 to $8.03.
• Similar sales were also conducted by George Jay Goldsmith, Malievskaia's spouse, under a separate 10b5-1 plan.
• Following these transactions, Malievskaia directly owns 3,929,413 shares and indirectly owns 3,931,687 shares through her spouse.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing share sales by a company director under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment.

Industry Context

Sales by company directors are a normal part of business, but are closely watched by investors. Sales under a 10b5-1 plan are less concerning as they are pre-arranged.

Stakeholder Impact

• Shareholders may react to the news of insider selling, although the pre-planned nature of the sales mitigates potential concerns.

Key Dates